SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Manulife Financial Corporation (MNLCF) trades at a trailing P/E of 5.5, forward P/E of 3.7. Trailing earnings yield is 18.05%, forward earnings yield 27.03%. PEG 0.72 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (5.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.72); earnings yield beats bond yields (18.05%).
- Forward P/E 3.7 (down from trailing 5.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.72 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 18.05% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 27.03% as earnings recover.
Overall SharesGrow Score: 69/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MNLCF
Valuation Multiples
P/E (TTM)5.5
Forward P/E3.7
PEG Ratio0.72
Forward PEG0.07
P/B Ratio0.00
P/S Ratio0.40
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.07
Forward EPS (Est.)$4.59
Book Value / Share$0.00
Revenue / Share$42.62
FCF / Share$0.00
Yields & Fair Value
Earnings Yield18.05%
Forward Earnings Yield27.03%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.41 |
$51.69B |
$2.99B |
5.8% |
| 2017 |
$0.98 |
$56.65B |
$2.07B |
3.7% |
| 2018 |
$2.35 |
$37.26B |
$4.67B |
12.5% |
| 2019 |
$2.77 |
$77.82B |
$5.27B |
6.8% |
| 2020 |
$2.93 |
$77.12B |
$5.33B |
6.9% |
| 2021 |
$3.54 |
$59.84B |
$6.66B |
11.1% |
| 2022 |
$-1.10 |
$15.96B |
$-2.1B |
-13.2% |
| 2023 |
$2.61 |
$50.33B |
$5.46B |
10.9% |
| 2024 |
$2.85 |
$17.48B |
$5.63B |
32.2% |
| 2025 |
$3.07 |
$53.01B |
$5.78B |
10.9% |
